Avoca s Quality Metrics Consulting Service Offering

Size: px
Start display at page:

Download "Avoca s Quality Metrics Consulting Service Offering"

Transcription

1 Avoca s Quality Metrics Consulting Service Offering

2 Avoca s Quality Metrics Consulting The Challenge Biopharmaceutical companies and CROs struggle in defining how best to utilize quality metrics to optimize quality outcomes. For some organizations, this means knowing how to measure aspects of quality that are meaningful across global matrixed organizations, and how to eliminate metrics that are not adding value. For others, it means understanding how best to organize and synthesize qualityrelated measurements and associated information so that meaningful, actionable conclusions can be drawn and to achieve improved project outcomes. Many organizations also require improvement in defining the roles, responsibilities, and processes surrounding the assembly, review, and analysis of metrics that will result in the greatest value. These may vary based on an organization s structure and outsourcing model. - Clinical Trials Transformation Initiative definition 2

3 Avoca s Quality Metrics Consulting The Avoca Solution Effective design, organization, and use of quality metrics to improve clinical trial operations and optimize quality outcomes. Avoca will support your efforts to improve quality outcomes and partnerships by designing a quality metrics framework tailored to your organization and its unique outsourcing/operational model. Avoca will improve your metric-related processes, allowing your organization to get the greatest possible benefit from your metrics collection investment. Avoca consultants will provide you expertise based on 15+ years of industry experience to help get the job done and ensure the most effective use and optimization of quality metrics. Our methodology and approach are outlined in the following slides. 3

4 Avoca s Quality Metrics Consulting Avoca s Unique Perspective & Experience The Avoca Group formed The Avoca Quality Consortium in 2011, which now brings together 40 member companies (comprised of pharma, biotech, CROs, and specialty clinical service providers) to develop industry standards and leading practices in proactive quality management and risk mitigation in outsourced clinical research. Through our experience and work in the Consortium, Avoca has evaluated many companies quality metrics, including the use and application of quality metrics in clinical development. This provides us with a unique perspective that enables us to provide feedback on an organization s suite of quality metrics. Avoca has developed a taxonomy and framework for quality metrics that is being adopted by top organizations in our industry. All Avoca Senior Consultants have first-hand experience in clinical development and the use of metrics in a clinical setting for biopharmaceutical companies and/or CROs. Avoca has supported top ten pharmaceutical companies with quality metrics consulting. Avoca is able to support a sponsor in conjunction with its CRO partners. 4

5 Avoca s Quality Metrics Consulting: Approach Avoca s quality metrics consulting is customized based on each organization s unique objectives and challenges, but typically follows a phased approach methodology: Define: Evaluate: Analyze: Identify: Recommend: What are your organization's objectives for the Quality Metrics Program? What is the current approach to measuring quality, who are the key stakeholders and what are their roles? What are the needs and gaps? What improvements will have the greatest impact? Actions, Timeline, and Next Steps 5

6 Avoca s Quality Metrics Consulting: Deliverables NEEDS ASSESSMENT Summary report that includes the collection of needs information via interviews with key stakeholders. A systematic assessment of your organization s existing metrics and metricsrelated reporting, analysis and review processes. Determines: Metrics Process Efficiency Utility of Metrics for Quality Oversight Quality of Metrics Design Integration of Metrics within the overall QMS GAP ANALYSIS Identification of improvements needed that will have the greatest impact. This may include a technology assessment, which evaluates systems and their utility in meeting quality metric collection, reporting and visualization objectives. IMPROVEMENT RECOMMENDATIONS Strategy document with recommended action plan for process improvement. Avoca s Senior Consultants will facilitate a Strategy Session with key stakeholders to review the information collected, and discuss next steps. 6

7 Avoca s Quality Metrics Consulting: Needs Assessment Avoca evaluates metrics and processes surrounding metrics. The following are some of the typical areas assessed during this evaluation: Is the distribution of metrics appropriate, offering sufficient but not excessive oversight in all key quality-related outcome and process areas? Are quality metrics organized in such a manner that they can align easily with other sources of quality-related information in order to support comprehensive quality management? Is there clear assignment of purpose of each metric? Are the metrics practical? Is the design of metrics generally appropriate, offering consistent rigor and fit for purpose? Is the suite of metrics organized in a manner that offers sufficient cross-functional and crossmanagement level awareness of and insight into how the organization is performing from a quality management perspective? Is there a clear line of sight from processes being performed to outcomes/value creation? Is there a focus on tasks that create the most value? Have levels of need for metrics been fully identified and are the available reports and roles with respect to review/analysis of quality metrics clear and appropriate according to this structure? Are processes with respect to the population of quality metrics clear, efficient, and effective? Does the suite of quality metrics provide a sufficient balance of leading metrics to ensure the ability to act proactively? Avoca provides supports to our clients in addressing the gaps identified following the Needs Assessment. 7

8 Avoca s Quality Metrics Consulting: Providing Improvement Recommendations ü Avoca will deliver a Strategy Document, which summarizes specific gaps and needs and outlines overarching recommendations. This is reviewed with key stakeholders during a Strategy Session. ü Avoca will provide an Implementation Plan, which includes actions, next steps and a proposed timeline for change. Avoca will consult with alliance partners/other vendors as part of this process, where appropriate. ü In some cases, Avoca provides a Communication Plan, which outlines a leading practice approach for engaging key stakeholders and communicating changes in a company s quality metrics program. ü Avoca provides Execution Support Services to assist our clients in implementing a new quality metrics program and in support of an organization s change management efforts, if desired. 8

9 The Avoca Group Client List Alexion Grünenthal Acurian Marken Pharmaceutical/Biotech AstraZeneca BioMarin Boehringer-Ingelheim Bristol-Myers Squibb Cadence Celtic Pharma Centocor Cerexa Cordis CR Bard Cubist Eisai Endo Pharmaceuticals Ethicon Ferring Pharmaceuticals Johnson & Johnson J&J Pharmaceutical Research Development Millennium Novartis Novo Nordisk Ortho Biotech Ortho Clinical Pfizer Purdue Pharma Regeneron Roche Terumo The Medicines Company Vertex Service Providers Aptiv Solutions Beardsworth BioClinica CenterPoint Chiltern Clinical Financial Services CRF Health ERT ExecuPharm Greenphire ICON Clinical Research Idis INC Research Indegene inventiv Health Clinical LabCorp MedAvante Medical Research Consultants Medidata PAREXEL PPD PRA International Quest Diagnostics Clinical Trials Quintiles REGISTRAT-MAPI ResearchPoint Schulman Associates IRB Synarc Theorem TKL Research Worldwide Clinical Trials 9

10 Contact Avoca at: (609) Nassau Street Suite 3A Princeton, NJ 08542

The 2015 Avoca Report. Clinical Development Innovation. Sponsor and Provider Views on Innovation in Outsourced Clinical Development

The 2015 Avoca Report. Clinical Development Innovation. Sponsor and Provider Views on Innovation in Outsourced Clinical Development The 2015 Avoca Report Clinical Development Innovation Sponsor and Provider Views on Innovation in Outsourced Clinical Development Contents Section Slides Research Overview 3-5 Respondent Demographics 6-9

More information

2015 Initiatives for Proactive Quality Management. Progress through Collaboration

2015 Initiatives for Proactive Quality Management. Progress through Collaboration 2015 Initiatives for Proactive Quality Management Progress through Collaboration 1 2015 AQC Members 2 The Avoca Quality Consortium Accelerating the development of leading practices and industry standards

More information

6 th Proactive GCP Compliance Effective Risk- Based Approaches for Optimizing Clinical Quality

6 th Proactive GCP Compliance Effective Risk- Based Approaches for Optimizing Clinical Quality 6 th Proactive GCP Compliance Effective Risk- Based Approaches for Optimizing Clinical Quality March 24-25, 2015 Wyndham Philadelphia Historic District, Philadelphia, PA www.exlevents.com/gcp Sponsors

More information

Bridging Clinical Trial Innovation and Quality

Bridging Clinical Trial Innovation and Quality May 13-14, 2015 (Preliminary Agenda as of April 3, 2015) Bridging Clinical Trial Innovation and Quality The Westin Princeton at Forrestal Village 201 Village Boulevard Princeton, NJ 08540 Confirmed Speakers

More information

To know more about Pharmacovigilance and Clinical Trials Data Management

To know more about Pharmacovigilance and Clinical Trials Data Management To know more about Pharmacovigilance and Clinical Trials Data Management 1. What is Pharmacovigilance? Pharmacovigilance (PV) is the pharmacological science related to the detection, assessment, understanding

More information

APAC CRO Market A deep dive into the trends transforming APAC CRO industry. P86A-52 June 2015

APAC CRO Market A deep dive into the trends transforming APAC CRO industry. P86A-52 June 2015 APAC CRO Market A deep dive into the trends transforming APAC CRO industry June 2015 Table of Contents Section Slide Numbers Executive Summary 10 Key Findings 11 Total CRO Market Size By Stages of Clinical

More information

CONTRACT RESEARCH ORGANIZATION INDUSTRY OVERVIEW

CONTRACT RESEARCH ORGANIZATION INDUSTRY OVERVIEW CONTRACT RESEARCH ORGANIZATION INDUSTRY OVERVIEW April 2014 Investment banking services are provided by Harris Williams LLC, a registered broker-dealer and member of FINRA and SIPC, and Harris Williams

More information

Clinical trial research agreement Agreed schedule 4 or 7 clause amendments

Clinical trial research agreement Agreed schedule 4 or 7 clause amendments Clinical trial research agreement Agreed schedule 4 or 7 clause amendments Medicines Australia and Medical Technology Association of Australia templates The sponsors in the table have agreed clauses for

More information

Time and Cost Reduction in Clinical Trials- Outsourcing and IT to Optimize Patient Recruitment, Logistics, Data and Site Management

Time and Cost Reduction in Clinical Trials- Outsourcing and IT to Optimize Patient Recruitment, Logistics, Data and Site Management Time and Cost Reduction in Clinical Trials- Outsourcing and IT to Optimize Patient Recruitment, Logistics, Data and Site Reference Code: GBIHC088MR Publication Date: June 2011 Biopharmaceutical companies

More information

Pharmacovigilance Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013-2019 Single User License: US $ 4595

Pharmacovigilance Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013-2019 Single User License: US $ 4595 Transparency Market Research Pharmacovigilance Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013-2019 Single User License: US $ 4595 Buy Now Request Sample Published Date:

More information

Meeting Priorities of Biotech & Small Pharma Companies

Meeting Priorities of Biotech & Small Pharma Companies Meeting Priorities of Biotech & Small Pharma Companies Dr. Andreas Orfanos, MBBCH,FFPM,MBA Thrasos Therapeutics Inc. Vice President Clinical Research & Development 28 Oct 2015 Montreal Technoparc Private,

More information

Later-Stage Development: Ensuring Compliance During. for a Competitive Advantage Webinar Series

Later-Stage Development: Ensuring Compliance During. for a Competitive Advantage Webinar Series Part II: Later-Stage Development: Ensuring Compliance During Clinical i l Trials Process Driven Compliance for a Competitive Advantage Webinar Series 29 September 2010 Process Driven Compliance Webinar

More information

In-depth analysis of the report is based on propriety databases, primary and secondary research and inhouse analysis by a team of experts.

In-depth analysis of the report is based on propriety databases, primary and secondary research and inhouse analysis by a team of experts. Brochure More information from http://www.researchandmarkets.com/reports/1882193/ Top 20 Contract Research Organizations (CRO) - Asia-Pacific, Especially India and China, Positioned to Benefit from Rising

More information

Clinical Supply Chain Management. Technologies such as IVRS, CTMS, EDC and RFID Enhance Drug Supply Management

Clinical Supply Chain Management. Technologies such as IVRS, CTMS, EDC and RFID Enhance Drug Supply Management Clinical Supply Chain Management Technologies such as IVRS, CTMS, EDC and RFID Enhance Drug Supply Management GBI Research Report Guidance GBI Research Report Guidance The report focuses on the current

More information

Establish Collaborative Strategies to Better Manage a Global Vendor Network Devise a Proper Float Plan

Establish Collaborative Strategies to Better Manage a Global Vendor Network Devise a Proper Float Plan Establish Collaborative Strategies to Better Manage a Global Vendor Network Devise a Proper Float Plan CBI s Biopharmaceutical Forum on Clinical and Commercial Global Supply Chain Excellence Sandy Onorato

More information

PROVENTA INTERNATIONAL INNOVATION. Strategies for Transforming Safety, Regulatory, and Benefit-Risk Management of Established Products

PROVENTA INTERNATIONAL INNOVATION. Strategies for Transforming Safety, Regulatory, and Benefit-Risk Management of Established Products INNOVATION SPOTLIGHT SESSION Strategies for Transforming Safety, Regulatory, and Benefit-Risk Management of Established Products WEDNESDAY 4TH NOVEMBER 2015 Hyatt Regency, Princeton, NJ PROVENTA INTERNATIONAL

More information

Pharma s Sharp Right Turn on R&D Creating an IT Platform to Fuel Future Growth

Pharma s Sharp Right Turn on R&D Creating an IT Platform to Fuel Future Growth Accenture Life Sciences Rethink Reshape Restructure for better patient outcomes Pharma s Sharp Right Turn on R&D Creating an IT Platform to Fuel Future Growth Leading pharmaceutical companies are evaluating

More information

Sparta Systems. Proven Enterprise Quality Management Solutions

Sparta Systems. Proven Enterprise Quality Management Solutions Sparta Systems Proven Enterprise Quality Management Solutions Sparta Systems global enterprise quality management solutions (EQMS) enable high-value organizations to safely and efficiently deliver products

More information

Managing and Integrating Clinical Trial Data: A Challenge for Pharma and their CRO Partners

Managing and Integrating Clinical Trial Data: A Challenge for Pharma and their CRO Partners Managing and Integrating Clinical Trial Data: A Challenge for Pharma and their CRO Partners Within the Pharmaceutical Industry, nothing is more fundamental to business success than bringing drugs and medical

More information

In the largest and perhaps the most ambitious collaborative

In the largest and perhaps the most ambitious collaborative FEATURES THE BIRTH OF TRANSCELERATE BIOPHARMA, INC. Revolution in Clinical Research Partnerships by Dalvir Gill and Garry Neil In the largest and perhaps the most ambitious collaborative effort ever initiated

More information

Stakeholder Guide 2014 www.effectivehealthcare.ahrq.gov

Stakeholder Guide 2014 www.effectivehealthcare.ahrq.gov Stakeholder Guide 2014 www.effectivehealthcare.ahrq.gov AHRQ Publication No. 14-EHC010-EF Replaces Publication No. 11-EHC069-EF February 2014 Effective Health Care Program Stakeholder Guide Contents Introduction...1

More information

Taking Strategic Partnerships to the Next Level: An Alternative Approach to Licensing Your Development Asset

Taking Strategic Partnerships to the Next Level: An Alternative Approach to Licensing Your Development Asset Taking Strategic Partnerships to the Next Level: An Alternative Approach to Licensing Your Development Asset Introduction In this era of strategic development deals, inventiv Health has significantly broadened

More information

Virtual Clinical Organization: The New Clinical Development Operating Model

Virtual Clinical Organization: The New Clinical Development Operating Model Cognizant 20-20 Insights Virtual Clinical Organization: The New Clinical Development Operating Model Executive Summary Clinical development executives are facing more pressure than ever to reduce costs

More information

Outsourcing Support Services Change Management Toolkit Preview Deck

Outsourcing Support Services Change Management Toolkit Preview Deck Outsourcing Support Services Management Toolkit Preview Deck Outsourcing Support Services (OSS) EG-PD-040 Management Toolkit Overview of toolkit Objective The change is designed to 1) assist the Buyer

More information

OUTPATIENT CLINICAL RESEARCH DEVELOPMENT

OUTPATIENT CLINICAL RESEARCH DEVELOPMENT OUTPATIENT CLINICAL RESEARCH DEVELOPMENT Forming a Strategic Partnership with Allied Clinical Research to Develop Potential Physicians Practices with Clinical Trial Capabilities Industry Statistics: 80%

More information

Blockbuster!!! Content Management in the Pharmaceutical Industry An Overview. Global Pharma Market Shares by Sales (Approx. USD 700 Billion) Global

Blockbuster!!! Content Management in the Pharmaceutical Industry An Overview. Global Pharma Market Shares by Sales (Approx. USD 700 Billion) Global Content Management in the Pharmaceutical Industry An Overview Blockbuster!!! Avatar USD 2 Billion revenues Lipitor USD 12.5 Billion in 2008 Dr Arun Gangatkar http://in.linkedin.com/in/drarungangatkar drarunj@gmail.com

More information

Beyond CTMS. Beyond Operational Metrics. True Performance.

Beyond CTMS. Beyond Operational Metrics. True Performance. Beyond CTMS. Beyond Operational Metrics. True Performance. Smart Data. Smarter Decisions. The power of performance analytics for those on the front lines of clinical research. The Performer platform keeps

More information

Transforming CliniCal Trials: The ability to aggregate and Visualize Data Efficiently to make impactful Decisions

Transforming CliniCal Trials: The ability to aggregate and Visualize Data Efficiently to make impactful Decisions : The ability to aggregate and Visualize Data Efficiently to make impactful Decisions www.eclinicalsol.com White Paper Table of Contents Maximizing Your EDC Investment... 3 Emerging Trends in Data Collection...

More information

Bringing Order to Your Clinical Data Making it Manageable and Meaningful

Bringing Order to Your Clinical Data Making it Manageable and Meaningful CLINICAL DATA MANAGEMENT Bringing Order to Your Clinical Data Making it Manageable and Meaningful eclinicalsol.com DATA IS SIMPLY BEAUTIFUL DATA STACKS IN STANDARD FORMATION This imaginative visual suggests

More information

Pharmaceutical Compliance and Regulatory Congress 2009

Pharmaceutical Compliance and Regulatory Congress 2009 Pharmaceutical Compliance and Regulatory Congress 2009 Compliance Program Elements Track I: How Program Management Can Keep You On Track Edward H. Leskauskas Director, Compliance and Ethics Operations

More information

strategy Therapure Biopharma is open for business P.20 HOW TO CHOOSE INSIGHTS FOR THE LIFE SCIENCE INDUSTRY DECEMBER 2008 Volume 11 Number 12

strategy Therapure Biopharma is open for business P.20 HOW TO CHOOSE INSIGHTS FOR THE LIFE SCIENCE INDUSTRY DECEMBER 2008 Volume 11 Number 12 INSIGHTS FOR THE LIFE SCIENCE INDUSTRY DECEMBER 2008 Volume 11 Number 12 Therapure Biopharma is open for business P.20 HOW TO CHOOSE THE RIGHT outsourcing providers for your oncology clinical trials outsourcing

More information

THE BIOTECH & PHARMACEUTICAL INDUSTRY

THE BIOTECH & PHARMACEUTICAL INDUSTRY THE BIOTECH & PHARMACEUTICAL INDUSTRY ESSENTIAL CAREERS INFORMATION CALUM LECKIE KATIE BISARO CAREERS CONSULTANTS What we will cover Sector overview Types of role Graduate recruitment trends and issues

More information

RBM as Competitive Advantage for Mid-sized CROs

RBM as Competitive Advantage for Mid-sized CROs RBM as Competitive Advantage for Mid-sized CROs Cyntegrity s White Paper Applying RBM analytics to improve patient safety and preventive care Table of Contents Introduction...3 What is Data-driven RBM?...4

More information

e-labeling : innovation for patient or regulation nightmare Pharmapack Feb, 11 th, 2015

e-labeling : innovation for patient or regulation nightmare Pharmapack Feb, 11 th, 2015 e-labeling : innovation for patient or regulation nightmare Pharmapack Feb, 11 th, 2015 PHARMAPACK 2015 1 Mobile health x2 30 months 100 000 mapps Source: research2guidance, mhealth App Market Report 2013-2017

More information

Clinical Supply Chain Management - Technologies such as IVRS, CTMS, EDC and RFID Enhance Drug Supply Management

Clinical Supply Chain Management - Technologies such as IVRS, CTMS, EDC and RFID Enhance Drug Supply Management Brochure More information from http://www.researchandmarkets.com/reports/2226324/ Clinical Supply Chain Management - Technologies such as IVRS, CTMS, EDC and RFID Enhance Drug Supply Management Description:

More information

An Oracle White Paper June 2012. Increasing Planning Efficiency in Clinical Development

An Oracle White Paper June 2012. Increasing Planning Efficiency in Clinical Development An Oracle White Paper June 2012 Increasing Planning Efficiency in Clinical Development Introduction... 1 Planning Trends and Challenges Facing Clinical Development... 3 Industry Increasing Use of Software

More information

The Geography of Markets for Technology: Evidence from Bio- Pharmaceuticals

The Geography of Markets for Technology: Evidence from Bio- Pharmaceuticals The Geography of Markets for Technology: Evidence from Bio- Pharmaceuticals Michelle Gittelman Department of Business and Management Rutgers Business School Newark-New Brunswick, New Jersey The pharmaceutical

More information

Moving from Compliance to Competency for the Clinical Research Professional

Moving from Compliance to Competency for the Clinical Research Professional Click to Edit Master Title Style Moving from Compliance to Competency for the Clinical Research Professional Rebecca Li, PhD, Executive Director Building A Learning Community Among Key Stakeholders - 1

More information

A Comparison of Two Commonly Used CRO Resourcing Models for SAS/ Statistical Programmers R. Mouly Satyavarapu, PharmaNet/ i3, Ann Arbor, MI

A Comparison of Two Commonly Used CRO Resourcing Models for SAS/ Statistical Programmers R. Mouly Satyavarapu, PharmaNet/ i3, Ann Arbor, MI PharmaSUG 2012 - Paper MS11 A Comparison of Two Commonly Used CRO Resourcing Models for SAS/ R. Mouly Satyavarapu, PharmaNet/ i3, Ann Arbor, MI ABSTRACT: Why do we have Contract Research Organizations

More information

Workshop on Quality Risk Management Making Trials Fit for Purpose

Workshop on Quality Risk Management Making Trials Fit for Purpose Clinical Trials Transformation Initiative Workshop on Quality Risk Management Making Trials Fit for Purpose Andy Lee SVP, Global Clinical Operations, Genzyme Corporation August 23/24, 2011 Hyatt Regency,

More information

Clinical Trial Data Management Outsourcing India; A Review of Cost and Competition

Clinical Trial Data Management Outsourcing India; A Review of Cost and Competition Clinical Trial Data Management Outsourcing India; A Review of Cost and Competition Dr Umakanta Sahoo, General Manager, Chiltern International Private Limited, Mumbai, India -----------------------------------------------------------------------------------------------------------------

More information

APAC Contract Research Organisation (CRO) Market

APAC Contract Research Organisation (CRO) Market Brochure More information from http://www.researchandmarkets.com/reports/3308444/ APAC Contract Research Organisation (CRO) Market Description: The research service presents an overview and analysis of

More information

Achieving High Quality Clinical Research Seminar Series. March 19, 2014. Rebecca Gavitt, BSN, RN, CCRA Sue Parsons Nicolás Samper, MS CCRA

Achieving High Quality Clinical Research Seminar Series. March 19, 2014. Rebecca Gavitt, BSN, RN, CCRA Sue Parsons Nicolás Samper, MS CCRA Achieving High Quality Clinical Research Seminar Series March 19, 2014 Rebecca Gavitt, BSN, RN, CCRA Sue Parsons Nicolás Samper, MS CCRA Introduction Agenda Definition of a CRA What types of visits are

More information

Welcome to the training on the TransCelerate approach to Risk-Based Monitoring. This course will take you through five modules of information to

Welcome to the training on the TransCelerate approach to Risk-Based Monitoring. This course will take you through five modules of information to Welcome to the training on the TransCelerate approach to Risk-Based Monitoring. This course will take you through five modules of information to introduce you to the concepts behind risk-based monitoring,

More information

December 17, 2014 HOW PHARMA MARKETERS FIND AND SELECT DIGITAL MARKETING AGENCIES

December 17, 2014 HOW PHARMA MARKETERS FIND AND SELECT DIGITAL MARKETING AGENCIES December 17, 2014 HOW PHARMA MARKETERS FIND AND SELECT DIGITAL MARKETING AGENCIES by Dennis van Rooij with Tim van Tongeren EXECUTIVE SUMMARY More than half of pharma marketers don t or can t leverage

More information

OE PROJECT CHARTER TEMPLATE

OE PROJECT CHARTER TEMPLATE PROJECT : PREPARED BY: DATE (MM/DD/YYYY): Project Name Typically the Project Manager Project Charter Last Modified Date PROJECT CHARTER VERSION HISTORY VERSION DATE (MM/DD/YYYY) COMMENTS (DRAFT, SIGNED,

More information

Electronic systems in clinical trials. Investigator s perspective

Electronic systems in clinical trials. Investigator s perspective Electronic systems in clinical trials Investigator s perspective KATARINA BERNDTSSON BLOM STOCKHOLM 22 SEPT 2015 Katarina Berndtsson Blom MD Head of Clinic at Ladulaas Clinical Trials www.ladulaaskliniken.se

More information

Successful Strategic Partnering

Successful Strategic Partnering WHITE PAPER Successful Strategic Partnering December 2013 Written by: Brenda Hoeper Senior Vice President, Strategic Resourcing inventiv Health Clinical TABLE OF CONTENTS Introduction... 3 Laying the Foundation

More information

Mayo Alliance for Clinical Trials

Mayo Alliance for Clinical Trials Mayo Alliance for Clinical Trials A Division within Mayo Clinical Trial Services PROFESSIONAL CLINICAL TRIALS SERVICES ADVANCING PATIENT CARE THROUGH SCIENTIFIC DISCOVERY It is a great thing to make scientific

More information

August 2011. www.ppdi.com

August 2011. www.ppdi.com Innovative Technology Provides Seamless Data Integration Linking Clinical Trial Patient Data to Central Laboratory Data Via an Oracle -Based Exchange Platform August 2011 www.ppdi.com Introduction Drug

More information

Transforming relationships Unleashing innovation

Transforming relationships Unleashing innovation Transforming relationships Unleashing innovation Translating Discoveries Into Products A model for innovation driven economic growth Barbara Handelin, PhD 1 The Innovation Gap Economic Opportunity Industries

More information

Establishing and Managing a Vendor Network for Clinical Supply Manufacturing Services

Establishing and Managing a Vendor Network for Clinical Supply Manufacturing Services Reprinted from PHARMACEUTICAL ENGINEERING THE OFFICIAL TECHNICAL MAGAZINE OF ISPE MAY/JUNE 2013, VOL 33, NO 3 Copyright ISPE 2013 www.pharmaceuticalengineering.org supply chain management Establishing

More information

Biotechnology in North Carolina

Biotechnology in North Carolina Biotechnology in North Carolina UNC-DoD Roundtable Bio-supported Products and Systems for the National Defense September 16, 2004 Kenneth R. Tindall, Ph.D. Sr. V. P. for Science and Business Development

More information

Global Market Study on E-clinical Solution Software: Asia to Witness Highest Growth by 2020

Global Market Study on E-clinical Solution Software: Asia to Witness Highest Growth by 2020 Brochure More information from http://www.researchandmarkets.com/reports/3291836/ Global Market Study on E-clinical Solution Software: Asia to Witness Highest Growth by 2020 Description: E-clinical solution

More information

Execution in Clinical Research

Execution in Clinical Research TM TM Execution in Clinical Research Unrivaled CRA training program drives success for Sponsors. Sponsors have many choices in choosing development partners at the CRO level. The need for a documented

More information

Post-PharmD Industry Fellowship Opportunities and Proposed Guidelines for Uniformity

Post-PharmD Industry Fellowship Opportunities and Proposed Guidelines for Uniformity SPECIAL ARTICLE American Journal of Pharmaceutical Education 2009; 73 () Article 20. Post-PharmD Industry Fellowship Opportunities and Proposed Guidelines for Uniformity Paul A. Larochelle, PharmD, a *

More information

Patient Centric Monitoring Methodology

Patient Centric Monitoring Methodology Patient Centric Monitoring Methodology The ICON approach to risk based monitoring in clinical trials An ICON White Paper Introduction The pharmaceutical and CRO industries are undergoing a radical shift

More information

Pharma RepTrak 2015 The World s Most Reputable Pharmaceutical Companies

Pharma RepTrak 2015 The World s Most Reputable Pharmaceutical Companies Pharma RepTrak 2015 The World s Most Reputable Pharmaceutical Companies The Pharma Industry s Reputation in the Eyes of the General Public A Reputation Study with Consumers in 15 Countries RepTrak is a

More information

TALENT MANAGEMENT SOLUTIONS TO THE CRA SHORTAGE: Investing in a Global Talent Pool

TALENT MANAGEMENT SOLUTIONS TO THE CRA SHORTAGE: Investing in a Global Talent Pool TALENT MANAGEMENT SOLUTIONS TO THE CRA SHORTAGE: Investing in a Global Talent Pool inventivhealth.com/clinical Over the past few years, the field of clinical research has been hampered by a shortage of

More information

The power of creativity www.originbranding.com. Pharmaceutical Branding 2012

The power of creativity www.originbranding.com. Pharmaceutical Branding 2012 The power of creativity www.originbranding.com Pharmaceutical Branding 2012 We are an independent, boutique agency passionately focused on developing pharmaceutical brands. For over 15 years we have delivered

More information

The Role of the CRO in Effective Risk-Based Monitoring

The Role of the CRO in Effective Risk-Based Monitoring New Whitepaper The Role of the CRO in Effective Risk-Based Monitoring The clinical trial industry is evolving. In an effort to improve participant safety and data integrity, regulators are encouraging

More information

Rutgers Mini-MBA : BioPharma Innovation

Rutgers Mini-MBA : BioPharma Innovation Rutgers Mini-MBA : BioPharma Innovation Ga i n t h e s k i l l s to t r a n s f o r m scientific i n n ovat i o n i n to business success www.cmd.rutgers.edu/innovation Rutgers Mini-MBA : BioPharma Innovation

More information

Managing the Extended Clinical Supply Chain in an Outsourced World

Managing the Extended Clinical Supply Chain in an Outsourced World Managing the Extended Clinical Supply Chain in an Outsourced World Business Pressures on Sponsors, Contractors and CROs are Increasing Most recent research on clinical trials focuses on the outsourced

More information

Novartis Investigator Initiated Trials (IITs) Guidelines

Novartis Investigator Initiated Trials (IITs) Guidelines Novartis Investigator Initiated Trials (IITs) Guidelines Introduction and background As part of our commitment to delivering innovative therapies to patients worldwide, Novartis believes in the need to

More information

Future roles and opportunities for statisticians in pharmaceutical industry

Future roles and opportunities for statisticians in pharmaceutical industry Future roles and opportunities for statisticians in pharmaceutical industry H. Ulrich Burger 1), Stefan Driessen 2), Chrissie Fletcher 3), Michael Branson 4), Christoph Gerlinger 5) 1) Hoffmann-La Roche

More information

Medical Writing Takes Off in India

Medical Writing Takes Off in India Visit http://store.centerwatch.com to learn more about State of the Clinical Trials Industry 2008 Special Article Reprint For the latest news and views on the clinical trials industry visit ClinicalTrialsToday.com

More information

BEST PRACTICES RESEARCH

BEST PRACTICES RESEARCH 2013 Frost & Sullivan 1 We Accelerate Growth Entrepreneurial Company of the Year Award Pharmaceutical Knowledge Process Outsourcing North America, 2013 Frost & Sullivan s Global Research Platform Frost

More information

Waife & Associates, Inc. Finding Efficiency in Clinical Research

Waife & Associates, Inc. Finding Efficiency in Clinical Research W Finding Efficiency in Clinical Research Time waits for no company. We help biopharmaceutical companies build global competitive advantage in their clinical research operations. Why does this happen in

More information

Data Management Maturity Model. Overview

Data Management Maturity Model. Overview Data Management Maturity Model Overview UPMC Center of Excellence Pittsburgh Jul 29, 2013 Data Management Maturity Model - Background A broad framework encompassing foundational data management capabilities,

More information

PANAGORA PHARMA CUSTOMER EXPERIENCE SUMMIT 14

PANAGORA PHARMA CUSTOMER EXPERIENCE SUMMIT 14 PANAGORA PHARMA CUSTOMER EXPERIENCE SUMMIT 14 March 5-6, 2014 Princeton, NJ The Nassau Inn Identify, Prioritize and Solve Key Operational Challenges that Shape the Customer Experience in Pharma GOLD SPONSORS

More information

Management Review to Drive Quality and Business Improvement

Management Review to Drive Quality and Business Improvement Management Review to Drive Quality and Business Improvement Kathy Diemert Senior Director, Strategy and Systems, Global Quality Operations AstraZeneca Pharmaceuticals Alderley Park, UK Ron Stellon Vice

More information

Fleeing India: What Will Make Clinical Trials Flood Back?

Fleeing India: What Will Make Clinical Trials Flood Back? August 2014 Fleeing India: What Will Make Clinical Trials Flood Back? Ghida HARFOUCHE / Regional Consultant - Asia India s clinical trial industry has seen it all. In less than 10 years, the country has

More information

Leveraging SharePoint for Clinical Trial Management

Leveraging SharePoint for Clinical Trial Management Bringing your projects to a higher level SM Leveraging SharePoint for Clinical Trial Management 26 April 2011 Presented by Darcy Vieira, Cato Research Canada Jeremiah Rehm, BioClinica 1 2010 by Cato Research

More information

ESKISP6056.01 Direct security testing

ESKISP6056.01 Direct security testing Direct security testing Overview This standard covers the competencies concerning with directing security testing activities. It includes setting the strategy and policies for security testing, and being

More information

Business Systems Analyst Job Family

Business Systems Analyst Job Family Promotion Criteria Entry level requires several years of work experience, either in a business area, or programmer with involvement in business systems. Demonstrated ability to learn and apply technology.

More information

Pharma working capital performance highly variable

Pharma working capital performance highly variable April 2014 Pharma working capital performance highly variable 41 Billion in Excess Working Capital We last completed this survey in 2012. We expected that there would be a broad improvement across the

More information

Technology and Expertise Add Operational Value to Medical Device Trials

Technology and Expertise Add Operational Value to Medical Device Trials Technology and Expertise Add Operational Value to Medical Device Trials Copyright 2015 Medidata Solutions. Medidata Solutions and other trademarks reserved in the US and globally. Medidata and other marks

More information

Acknowledgements. We thank these organizations and individuals for their unrestricted support.

Acknowledgements. We thank these organizations and individuals for their unrestricted support. Power to the People Presented by Dawn Richards, PhD, Person with Rheumatoid Arthritis Arthritis Consumer Experts Advisory Board Member Canadian Arthritis Patient Alliance Vice President Acknowledgements

More information

U.S. Contract Research Outsourcing Market: Trends, Challenges and Competition in the New Decade. N8B7-52 December 2010

U.S. Contract Research Outsourcing Market: Trends, Challenges and Competition in the New Decade. N8B7-52 December 2010 U.S. Contract Research Outsourcing Market: Trends, Challenges and Competition in the New Decade December 2010 Table of Contents Notes on Methodology 8 Market Introduction and Segmentation Introduction

More information

Hollie Goddard Sr. IRB Coordinator McKesson Specialty Health

Hollie Goddard Sr. IRB Coordinator McKesson Specialty Health Hollie Goddard Sr. IRB Coordinator McKesson Specialty Health We are responsible for acquiring, analyzing, and protecting medical information vital to providing quality patient care HIM professionals ensure

More information

ESKITP7145.01 Manage IT service delivery performance metrics

ESKITP7145.01 Manage IT service delivery performance metrics Overview This sub-discipline covers the competencies required to manage the monitoring, analysis and communication of IT service delivery performance metrics. Monitoring service level performance is a

More information

PARTIAL DELEGATE LIST (as of Jan. 15, 2013) Electronic Data in Clinical Trials /Integration and Leveraging Clinical Trial Operations Data Conferences

PARTIAL DELEGATE LIST (as of Jan. 15, 2013) Electronic Data in Clinical Trials /Integration and Leveraging Clinical Trial Operations Data Conferences PARTIAL DELEGATE LIST (as of Jan. 15, 2013) Electronic Data in Clinical Trials /Integration and Leveraging Clinical Trial Operations Data Conferences February 5-7, 2013 - Hyatt Regency Miami Miami, FL

More information

Innovations in Pharma Sales Operations

Innovations in Pharma Sales Operations Innovations in Pharma Sales Operations Sales Ops Importance in Pharma Pharmaceutical organizations are going through fundamental restructuring. They are facing changing regulations, intense cost pressure,

More information

KEY INSIGHTS FROM CAMPBELL ALLIANCE S THIRD ANNUAL US MEDICAL AFFAIRS LEADERSHIP SUMMIT

KEY INSIGHTS FROM CAMPBELL ALLIANCE S THIRD ANNUAL US MEDICAL AFFAIRS LEADERSHIP SUMMIT KEY INSIGHTS FROM CAMPBELL ALLIANCE S THIRD ANNUAL US MEDICAL AFFAIRS LEADERSHIP SUMMIT Introduction For the third year running, Campbell Alliance brought together Medical Affairs (MA) leaders from a diverse

More information

Clinical Trial Supply Europe 2016 Barcelona, 2 nd & 3 rd March 2016 2016 SPEAKERS INCLUDE

Clinical Trial Supply Europe 2016 Barcelona, 2 nd & 3 rd March 2016 2016 SPEAKERS INCLUDE Clinical Trial Supply Europe 2016 Barcelona, 2 nd & 3 rd March 2016 2016 SPEAKERS INCLUDE Jan-Pieter Kappelle, Senior Director, Global Clinical Trial Supplies, UCB Didier Basseras, Vice President, Clinical

More information

1) SCOPE OF THE PROGRAM

1) SCOPE OF THE PROGRAM CALL FOR PROJECTS 2015/16 CANADA/GERMANY JOINT PROGRAM DEADLINE: 15 TH JANUARY 2016 1) SCOPE OF THE PROGRAM The main goal of the Canada/Germany joint program is to strengthen research in Canada and Germany

More information

Waife & Associates, Inc. Change Management for Clinical Research

Waife & Associates, Inc. Change Management for Clinical Research Waife & Associates, Inc. Change Management for Clinical Research There is a light through the fog We help biopharmaceutical companies build global competitive advantage in their clinical research operations.

More information

QUALITY CONTROL AND QUALITY ASSURANCE IN CLINICAL RESEARCH

QUALITY CONTROL AND QUALITY ASSURANCE IN CLINICAL RESEARCH QUALITY CONTROL AND QUALITY ASSURANCE IN CLINICAL RESEARCH Martin Valania, Executive Director, Corporate QA and Compliance Introduction Pharmaceutical companies recognize the benefits of carefully managing

More information

Pharmaceutical Marketing Disclosures

Pharmaceutical Marketing Disclosures Pharmaceutical Marketing Disclosures July 1, 2007 June 30, 2008 Report of Vermont Attorney General William H. Sorrell April 2009 Prepared by staff of the Vermont Attorney General s Office: Wendy Morgan,

More information

Enabling Portfolio Management Value Realization A BioPharma PMO Imperative. Roger E. Williams & Fergus Delappe Bristol-Myers Squibb PMO15BR23

Enabling Portfolio Management Value Realization A BioPharma PMO Imperative. Roger E. Williams & Fergus Delappe Bristol-Myers Squibb PMO15BR23 Enabling Portfolio Management Value Realization A BioPharma PMO Imperative Roger E. Williams & Fergus Delappe Bristol-Myers Squibb PMO15BR23 Agenda & Goals Background and understanding the complexity of

More information

Best Practices in Outsourcing Clinical Trials for Medical Device Companies

Best Practices in Outsourcing Clinical Trials for Medical Device Companies GLOBAL MEDICAL DEVICE CRO Your goal is to give people a better quality of life. We re proud to be a part of your mission. Best Practices in Outsourcing Clinical Trials for Medical Device Companies This

More information

Teaching the Science of Quality Improvement to Graduate Students: Practical Steps for Success. Michelle Freeman PhD, RN

Teaching the Science of Quality Improvement to Graduate Students: Practical Steps for Success. Michelle Freeman PhD, RN Teaching the Science of Quality Improvement to Graduate Students: Practical Steps for Success Michelle Freeman PhD, RN University of Windsor Windsor, Ontario Faculty of Nursing Quality Improvement (QI)

More information

Clinical Trial Design

Clinical Trial Design March 16-17, 2015 Loews Philadelphia Hotel Philadelphia, PA Missing Data in Clinical Trials Discover the most effective strategies to identify, reduce and avoid the pitfalls of incomplete data in your

More information

INCENTIVE COMPENSATION CONFERENCE

INCENTIVE COMPENSATION CONFERENCE Announcing the 2nd Annual ZS Associates INCENTIVE COMPENSATION CONFERENCE 08 September 23 24, 2008 Philadelphia, PA Incentive compensation greatly affects sales force motivation and morale. When designed

More information

Profile of Biomedical Research and Biotechnology Commercialization. Philadelphia Wilmington Atlantic City Consolidated Metropolitan Statistical Area

Profile of Biomedical Research and Biotechnology Commercialization. Philadelphia Wilmington Atlantic City Consolidated Metropolitan Statistical Area Profile of Biomedical Research and Biotechnology Commercialization Philadelphia Wilmington Atlantic City Consolidated Metropolitan Statistical Area Overview and History of Biotechnology in Metropolitan

More information

2016 Industry Survey Pursuing World Class RIM: Strategy, Measures and Priorities. Study Fast Facts

2016 Industry Survey Pursuing World Class RIM: Strategy, Measures and Priorities. Study Fast Facts 2016 Industry Survey Pursuing World Class RIM: Strategy, Measures and Priorities Study Fast Facts December 18 th 2015 SURVEY BACKGROUND Gens & Associates Life Science research projects are renowned for

More information

IT Professional Standards. Information Security Discipline. Sub-discipline 605 Information Security Testing and Information Assurance Methodologies

IT Professional Standards. Information Security Discipline. Sub-discipline 605 Information Security Testing and Information Assurance Methodologies IT Professional Standards Information Security Discipline Sub-discipline 605 Information Security Testing and Information Assurance Methodologies December 2012 Draft Version 0.6 DOCUMENT REVIEW Document

More information

How To Improve Project Management

How To Improve Project Management PRTM Global Management Consultants Successful Portfolio and Resource Management Practices for Pharmaceutical & Biopharmaceutical Companies Industry Benchmarking Report For further information, contact:

More information

Director, Office of Health IT and e Health; State Government HIT Coordinator. Deputy Director, Office of Health IT and e Health

Director, Office of Health IT and e Health; State Government HIT Coordinator. Deputy Director, Office of Health IT and e Health Assignment Location: Minnesota Department of Health St. Paul, Minnesota Primary Mentor: Secondary Mentor: Martin LaVenture, PhD, MPH, FACMI Director, Office of Health IT and e Health; State Government

More information

Life Sciences Outlook. New Jersey 2015

Life Sciences Outlook. New Jersey 2015 Life Sciences Outlook New Jersey 2015 New Jersey M&A activity in New Jersey has led to the consolidation of surplus real estate holdings and diminished head counts. However, midsized companies are helping

More information